Figure 1

Cell survival of malignant and nonmalignant cell lines treated with the increasing concentration of doxorubicin, BS-RNase or HHP2-RNase. The average results±s.d. of three independent determinations. Cells were exposed to each molecule for 24 h. After 3 weeks, cell survival was measured by counting colony-forming units.